Publication: 2903

Publication: 2903

A phase II study of pre- and post-operative gemcitabine and erlotinib plus pancreaticoduodenectomy (PD) for patients with resectable pancreatic ductal adenocarcinoma (PDAC): ACOSOG/ Alliance Z5041 Trial

URL

Google Scholar

Citation:: J Clin Oncol vol 36 (15_suppl) 4112

Meeting Instance:: ASCO 2018
Year:: 2018
Type:: Abstract
Sub type:
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 3037

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882

Corr. Author:
Authors:: Alice Chia-chi Wei Fang-Shu Ou Qian Shi Eileen Mary O'Reilly Jeffrey A. Meyerhardt Robert A. Wolff Hedy L. Kindler Douglas B. Evans Vikram Deshpande Joseph Misdraji Eric P. Tamm Dushyant Sahani Malcolm J. Moore Elliot Newman Nipun B. Merchant Jordan Berlin Laura Williams Goff Peter W. T. Pisters Mitchell C. Posner

Networks:: 11030, FL028, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NY016, LAPS-TN008, LAPS-TX035, LAPS-WI013, NORTHWELL

Study: ACOSOG-Z5041
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: